Medicana Health Group Launches HPV Vaccination And Cervical Cancer Awareness Campaign, Advancing Prevention Through Regular Check-Ups

(MENAFN- GlobeNewsWire - Nasdaq) Aligned with World Immunization Week 2026, the initiative combines public education, and a long-term prevention strategy through regular check-ups, targeting 25,000 vaccinations annually

Photo: Medicana Ataköy Hospital in Istanbul via FL Comms

ISTANBUL, Türkiye, April 24, 2026 (GLOBE NEWSWIRE) -- Medicana Health Group has launched a new HPV vaccination and cervical cancer awareness campaign designed to expand prevention, strengthen public understanding, and reinforce trust in evidence-based care. Timed with World Immunization Week 2026, observed from 24 to 30 April under the World Health Organization's theme “For every generation, vaccines work,” the initiative places HPV prevention within a broader life-course immunization agenda. In the first phase of the campaign the Group works toward an annual target of 25,000 vaccinations. (WHO )

This initiative reflects Medicana Health Group's broader commitment to advancing preventive care through accessible, institution-led health solutions. By combining a long-term awareness campaign with a follow-up framework, Medicana positions itself as a healthcare brand that connects global health priorities with measurable local action.

According to the World Health Organization, human papillomavirus (HPV) is the most common viral infection of the reproductive tract, and nearly all cases of cervical cancer are linked to persistent infection with oncogenic HPV. Cervical cancer remains the fourth most common cancer among women globally, with an estimated 660,000 new cases in 2022, underscoring the importance of coordinated strategies that bring together vaccination, screening, regular follow-up and timely treatment.

Medicana's campaign which encourages public and their staff to get vaccinated highlights the importance of institution-supported access and reinforces the Group's role in expanding preventive healthcare pathways. Through this initiative, Medicana not only supports earlier action against cervical cancer risk but also strengthens its international profile as a health group investing in prevention, continuity of care and women's health.

THE CRITICAL ROLE OF REGULAR CHECK-UPS
Medicana's campaign is designed not only to promote HPV vaccination, but also to raise awareness of the full prevention pathway in cervical cancer care. Vaccination plays a key role in reducing risk before disease develops; however, regular medical follow-up and appropriate screening are equally important for detecting potential risks at an early stage. This prevention-to-treatment continuum reflects the World Health Organization's cervical cancer elimination framework, which emphasizes HPV vaccination, screening at recommended ages, and timely access to treatment when precancerous lesions or invasive disease are identified.

In line with this approach, Medicana Health Group highlights the importance of regular check-ups as an essential part of preventive healthcare. Through its different check-up packages, Medicana offers individuals the opportunity to include relevant examinations and screenings, including gynecological evaluation and physician-recommended tests where appropriate. By combining vaccination awareness with regular controls and early diagnosis, Medicana aims to support individuals in taking proactive steps to protect their long-term health.

MENAFN24042026004107003653ID1111028333